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Recent evidence suggests that the prevalence of various
allergic conditions such as allergic rhinitis, food allergy
and eosinophilic esophagitis (EoE) is on the rise [1-3].
Over the last decade, there have been significant
advances in our current understanding of these as well
as other common allergic and immunological diseases.
The purpose of this supplement entitled, AP r a c t i c a l
Guide for Allergy and Immunology in Canada, is to pro-
vide medical students, medical residents, primary-care
practitioners and other healthcare professionals with a
comprehensive, yet easy-to-follow, series of articles on
all of the common conditions we deal with in the field
of allergy and immunology.
The first article provides a basic introduction to the
main components and function of the immune system
and its role in both health and disease, and also serves
as a background to the immunopathological disorders
discussed in the remainder of this supplement, including
asthma, allergic rhinitis, atopic dermatitis (AD), anaphy-
laxis, food allergy, EoE, urticaria, angioedema, drug
allergy and primary immunodeficiency disorders (PIDs).
Asthma remains the most common chronic respiratory
disease in Canada [4], and despite significant improve-
ment in the diagnosis and management of this disorder,
the majority of Canadians with asthma remain poorly
controlled [5]. Allergic rhinitis frequently coexists with
asthma [6], and it is often a long-standing condition
that goes undetected in the primary-care setting. AD is
one of the most common skin disorders in children [7],
and is often the initial step in the “atopic march” (the
sequential development of allergic disease manifestations
during early childhood), which leads to asthma and/or
allergic rhinitis in the majority of afflicted patients [8].
Often referred to as “asthma of the esophagus”,E o Ei s
an atopic inflammatory disease of the esophagus that
has also become increasingly recognized over the last
decade. This supplement provides an overview of the
epidemiology and pathophysiology of these common
allergic conditions as well as practical strategies for their
diagnosis and management.
Allergen-specific immunotherapy is the only poten-
tially disease-modifying therapy for allergic disease and
has been proven to be effective for the treatment of
allergic rhinitis/conjunctivitis, allergic asthma and sting-
ing insect hypersensitivity. However, despite its proven
efficacy, it is frequently underutilized in Canada. In this
supplement, the authors review the indications and con-
traindications, patient selection criteria, and the admin-
istration, safety and efficacy of allergen-specific
immunotherapy.
Anaphylaxis is an acute, potentially fatal systemic
reaction that requires prompt recognition and treat-
ment; however, both patients and healthcare profes-
sionals often fail to recognize and diagnose its early
signs and symptoms. The accurate diagnosis and appro-
priate management of food allergy is also critical since
accidental exposure to even minute quantities of the
“culprit” food may result in anaphylaxis. In this supple-
ment, the authors discuss the causes, clinical features,
diagnosis and management of anaphylaxis and food
allergy. The authors also review the pathophysiology,
diagnosis and treatment of urticaria (hives) and the
work-up and management of isolated angioedema (swel-
ling that occurs beneath the skin), which vary consider-
ably from that of angioedema that occurs in the
presence of urticaria. Although isolated angioedema is
often self-limited, laryngeal involvement can lead to fatal
asphyxiation in some cases; therefore, prompt recogni-
tion and management are imperative.
Drug allergy encompasses a spectrum of immunologi-
cally-mediated hypersensitivity reactions that not only
affect patient quality of life, but that may also lead to
delayed treatment, unnecessary investigations, and even
mortality. In this supplement, the authors examine the
most common drug-induced allergic reactions, such
allergies to penicillin, sulfonamides, cephalosporins,
radiocontrast media, local anesthetics, general anes-
thetics, acetylsalicylic acid (ASA) and non-steroidal anti-
inflammatory drugs (NSAIDs). * Correspondence: hlkimkw@gmail.com
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major categories of PIDs (a heterogeneous group disor-
ders that result from defects in immune system develop-
ment and/or function). Although the clinical
manifestations of PIDs are highly variable, most disor-
ders involve an increased susceptibility to infection. In
fact, many PIDs present as “routine” respiratory infec-
tions and, therefore, maygo undetected in the primary-
care setting.
For each of the above-mentioned articles, key take-
home messages are summarized for quick reference and,
where applicable, easy-to-follow flow charts, tables and
algorithms are provided to assist clinicians in the identi-
fication, diagnosis and treatment of these common aller-
gic diseases. We are confident that readers will not only
find this supplement educational and informative, but
that it will also provide clinicians with a solid base of
knowledge and skills in allergy and immunology which
they can then incorporate into their respective clinical
practices to help improve the care and management of
patients with allergic disease. It is also our hope that
this supplement will spark further interest in these con-
ditions and in our specialty.
Finally, we would like to thank all of the authors who
set aside time from their numerous commitments to
write and review these informative articles, the peer
reviewers for providing their highly-valued feedback,
and the Canadian Society of Asthma and Clinical
Immunology and other sponsors who provided the sup-
port needed for the development of this important edu-
cational initiative.
We sincerely hope you enjoy this supplement!
Harold Kim, MD, FRCPCRichard Warrington, MB,
BS, PhD, FRCPCWade Watson, MD, MEd, FRCPC.
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